Balance Sheet Components

9 Months Ended

Dec. 31, 2022

Balance Sheet Related Disclosures [Abstract]

. Balance Sheet Components

Property and Equipment, Net

Property and equipment, net consisted of the following:


	December 31,			March 31,
	2022			2022
	(In thousands)
Computer and software	$	9,992		$	10,573
Laboratory equipment and software		52,159			51,557
Furniture and office equipment		9,117			8,926
Leasehold improvements		40,852			40,566
Capitalized asset retirement obligations		853		853
Property and equipment, gross		112,973			112,475
Less: accumulated depreciation and amortization		(72,182	)		(62,624	)
Property and equipment, net	$	40,791		$	49,851

Depreciation and amortization expense was $3.7 million and $3.9 million for the three months ended December 31, 2022 and 2021, respectively, and $11.5 million and $12.3 million for the nine months ended December 31, 2022 and 2021, respectively.

Internal-Use Software, Net

Internal-use software, net consisted of the following:


	December 31,			March 31,
	2022			2022
	(In thousands)
Capitalized internal-use software	$	22,128		$	14,804
Less: accumulated amortization		(8,305	)		(5,169	)
Internal-use software, net	$	13,823		$	9,635

The Company capitalized $3.5 million and $1.4 million in internal-use software during the three months ended December 31, 2022 and 2021, respectively, and $7.8 million and $3.6 million in internal-use software during the nine months ended December 31, 2022 and 2021, respectively. Impairment to internal-use software was zero and $0.5 million for the three and nine months ended December 31, 2022, respectively. There was no impairment to internal-use software for the three and nine months ended December 31, 2021. For the three months ended December 31, 2022 and 2021, amortization expense related to internal-use software was $1.1 million and $0.8 million, respectively. For the nine months ended December 31, 2022 and 2021, amortization expense related to internal-use software was $3.1 million and $2.1 million, respectively.

Intangible Assets, Net

Intangible assets, net consisted of the following:


	December 31, 2022
	Weighted Average Remaining Useful Life (Years)		Gross Carrying Amount		Accumulated Amortization			Cumulative Impairment Charge			Cumulative Currency Translation			Net Carrying Amount
	(In thousands, except years)
Customer relationships		0.8	$	14,900	$	(8,692	)	$	—		$	—		$	6,208
Partnerships		8.8		23,200		(4,160	)		(9,968	)		(1,122	)		7,950
Trademark		3.8		11,000		(2,567	)		—			—			8,433
Developed technology		5.8		24,100		(4,017	)		—			—			20,083
Non-compete agreements		3.8		2,800		(653	)		—			—			2,147
Patents		5.7		5,500		(959	)		—			—			4,541
Total intangible assets			$	81,500	$	(21,048	)	$	(9,968	)	$	(1,122	)	$	49,362


	March 31, 2022
	Weighted Average Remaining Useful Life (Years)		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In thousands, except years)
Customer relationships		1.6	$	14,900	$	(3,104	)	$	11,796
Partnerships		6.6		23,200		(1,558	)		21,642
Trademark		4.6		11,000		(917	)		10,083
Developed technology		6.6		24,100		(1,436	)		22,664
Non-compete agreements		4.6		2,800		(233	)		2,567
Patents		6.4		5,500		(347	)		5,153
Total intangible assets			$	81,500	$	(7,595	)	$	73,905

Amortization expense for intangible assets was $4.5 million and $3.0 million for the three months ended December 31, 2022 and 2021, respectively, and $13.4 million and $3.0 million for the nine months ended December 31, 2022 and 2021, respectively.

During the three months ended December 31, 2022, the Company recorded a $10.0 million impairment charge for the U.K. partnership asset group within sales and marketing expenses in its Consumer and Research segment.

Estimated future amortization expense of the identified intangible assets as of December 31, 2022 were as follows:


	Estimated Amortization
	(In thousands)
Fiscal years ending March 31,
2023 (Remaining three months)	$	3,842
2024		12,265
2025		7,919
2026		7,919
2027		6,770
Thereafter		10,647
Total estimated future amortization expense	$	49,362

Accrued Expense and Other Current Liabilities

Accrued expense and other current liabilities consisted of the following:


	December 31,		March 31,
	2022		2022
	(In thousands)
Accrued payables	$	16,922	$	20,937
Accrued compensation and benefits		37,859		14,898
Accrued clinical expenses		12,684		6,717
Accrued taxes and other		1,571		2,036
Total accrued expenses and other current liabilities	$	69,036	$	44,588